Which are the symptoms of Cowden syndrome?

TL;DR: Cowden syndrome is a rare genetic disorder characterized by the development of multiple noncancerous tumors called hamartomas and a significantly increased risk of developing certain cancers, particularly in the breast, thyroid, and uterus. Symptoms often manifest as mucocutaneous lesions, such as small bumps on the skin or inside the mouth, which frequently serve as the earliest clinical indicators of the condition.

What are the most common symptoms of Cowden syndrome?

The clinical presentation of Cowden syndrome is highly variable, but it is primarily defined by the growth of hamartomas—benign, tumor-like malformations. Most individuals with Cowden syndrome will develop mucocutaneous lesions by their late 20s. These typically include trichilemmomas (small, skin-colored bumps on the face), oral papillomas (bumpy growths on the gums or tongue), and acral keratoses (tiny, wart-like spots on the hands and feet). Beyond skin findings, patients often experience macrocephaly (an unusually large head circumference) and may have thyroid abnormalities, ranging from benign nodules to multinodular goiter.

What are the early warning signs to watch for?

Because Cowden syndrome is a multisystem disorder, early detection is vital for long-term management. Families should monitor for the following clinical signs:

• Mucocutaneous findings: Multiple facial papules or oral lesions appearing in early adulthood.


• Macrocephaly: A head circumference consistently above the 97th percentile.


• Thyroid issues: The presence of benign thyroid nodules or follicular thyroid adenoma.


• Gastrointestinal concerns: Multiple polyps found during routine screenings, which can occur throughout the digestive tract.


• Developmental delays: While not present in every case, some individuals with Cowden syndrome may experience mild intellectual disability or autism spectrum features.

How does disease severity and progression vary?

The severity of Cowden syndrome varies significantly even within the same family, a phenomenon known as variable expressivity. While some patients may have only mild skin manifestations, others face a high lifetime risk of malignancy. The primary concern for long-term quality of life is the increased susceptibility to cancers, specifically breast cancer (up to 85% lifetime risk in women), thyroid cancer, endometrial cancer, and renal cell carcinoma. Symptoms tend to progress as the patient ages, as the cumulative risk of tumor formation increases throughout the lifespan. Regular surveillance is the standard of care to monitor for these changes.

When should I seek immediate medical attention?

Patients diagnosed with Cowden syndrome should maintain a low threshold for seeking medical care if they notice rapid changes in existing growths, unexplained weight loss, persistent abdominal pain, or the discovery of a new lump or mass. Because of the elevated cancer risk, any symptom that deviates from the patient's established baseline—such as sudden changes in bowel habits or the appearance of a hard, fixed mass—warrants an immediate consultation with an oncologist or genetic specialist.

Next steps

• Consult with a clinical geneticist to confirm your diagnosis and discuss familial testing.


• Establish a long-term cancer surveillance plan with an oncology team familiar with PTEN hamartoma tumor syndromes.


• Join the Cowden syndrome community on DiseaseMaps.org to connect with 116 other members who share your experience.


• Keep a detailed log of all skin lesions and internal screenings to share with your healthcare providers.

Medical disclaimer: This information is for educational purposes only and does not constitute professional medical advice, diagnosis, or treatment; always seek the advice of your physician or other qualified health provider with any questions regarding a medical condition.

References

• NIH Genetic and Rare Diseases Information Center (GARD): Cowden syndrome


• Orphanet: PTEN hamartoma tumor syndrome


• Online Mendelian Inheritance in Man (OMIM): Cowden syndrome (Entry #158350)


• National Comprehensive Cancer Network (NCCN) Guidelines for Genetic/Familial High-Risk Assessment: Breast, Ovarian, and Pancreatic